bf/NYSE:BBLN_icon.jpeg

COM:BABYLONHEALTH

Babylon Health

  • Stock

USD

Last Close

0.64

28/06 20:00

Market Cap

14.10M

Beta: -

Volume Today

419.17K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
4.87M
-
17.87M
266.80%
2.49M
86.06%
average payables
6.41M
-
15.16M
136.47%
16.14M
6.50%
average receivables
17.08M
-
20.01M
17.16%
37.75M
88.63%
book value per share
1.87
-
0.53
71.47%
14.80
2,670.46%
-13.88
193.79%
capex per share
-0.41
-
-0.40
1.91%
-3.60
798.16%
-0.46
87.18%
capex to depreciation
-15.20
-
-2.57
83.10%
-1.15
55.28%
-0.71
38.51%
capex to operating cash flow
0.26
-
0.26
1.78%
0.28
6.24%
0.03
90.09%
capex to revenue
-2.37
-
-0.47
80.16%
-0.12
73.48%
-0.01
93.84%
cash per share
2.31
-
1.10
52.65%
23.51
2,045.11%
2.36
89.97%
days of inventory on hand
52.89
-
32.76
38.06%
-6.99
121.33%
days payables outstanding
95.64
-
41.40
56.71%
28.59
30.96%
3.19
88.83%
days sales outstanding
415.63
-
73.22
82.38%
27.26
62.77%
16.90
38.01%
debt to assets
0.01
-
0.31
2,426.79%
0.33
4.35%
1.21
269.17%
debt to equity
0.02
-
1.51
7,221.97%
1.10
27.28%
-1.16
205.80%
dividend yield
earnings yield
-0.01
-
-0.01
34.03%
-0.23
2,671.84%
-1.78
673.39%
enterprise value
22.44B
-
22.63B
0.82%
1.55B
93.16%
378.17M
75.55%
enterprise value over ebitda
-140.88
-
-140.08
0.57%
-4.18
97.01%
-1.17
72.09%
ev to operating cash flow
-156.28
-
-157.76
0.95%
-10.60
93.28%
-1.21
88.55%
ev to sales
1.40K
-
285.45
79.61%
4.79
98.32%
0.34
92.88%
free cash flow per share
-1.96
-
-1.95
0.50%
-16.66
756.28%
-17.35
4.14%
free cash flow yield
-0.01
-
-0.01
0.50%
-0.11
1,333.50%
-2.57
2,148.57%
graham net net
1.22
-
-0.77
163.32%
-8.57
1,006.37%
-23.35
172.52%
graham number
7.98
-
4.93
38.16%
105.66
2,041.75%
61.24
42.04%
income quality
1.02
-
0.76
25.49%
0.39
48.94%
1.41
261.04%
intangibles to total assets
0.15
-
0.40
166.90%
0.37
8.66%
0
100%
interest coverage
-145.90
-
-38.74
73.44%
-28.17
27.30%
-10.29
63.45%
interest debt per share
0.05
-
0.86
1,589.42%
17.52
1,949.35%
17.89
2.11%
inventory turnover
6.90
-
11.14
61.43%
-52.22
568.74%
invested capital
0.02
-
1.51
7,221.97%
1.10
27.28%
-1.16
205.80%
market cap
22.65B
-
22.65B
0%
1.63B
92.81%
124.46M
92.35%
net current asset value
122.95M
-
-61.11M
149.70%
-72.66M
18.91%
-281.88M
287.94%
net debt to ebitda
1.33
-
0.17
87.44%
0.22
31.80%
-0.78
456.87%
net income per share
-1.51
-
-2.03
34.03%
-33.53
1,555.72%
-12.01
64.18%
operating cash flow per share
-1.55
-
-1.54
0.13%
-13.06
745.41%
-16.89
29.32%
payables turnover
3.82
-
8.82
131.00%
12.77
44.84%
114.34
795.48%
receivables turnover
0.88
-
4.98
467.61%
13.39
168.59%
21.60
61.33%
research and ddevelopement to revenue
3.19
-
0.45
85.97%
0.15
67.15%
0.07
51.54%
return on tangible assets
-0.57
-
-1.32
131.06%
-1.07
19.01%
-0.90
16.02%
revenue per share
0.17
-
0.85
394.40%
28.91
3,286.31%
60.18
108.15%
roe
-0.81
-
-3.79
369.74%
-2.27
40.24%
0.87
138.19%
roic
-0.87
-
-1.40
61.25%
-1.12
20.05%
-5.57
399.52%
sales general and administrative to revenue
4.30
-
1.09
74.73%
0.61
43.91%
0.21
66.27%
shareholders equity per share
1.87
-
0.53
71.47%
14.80
2,670.46%
-13.88
193.79%
stock based compensation to revenue
0.50
-
0.12
75.73%
0.14
18.95%
0.03
78.28%
tangible asset value
129.99M
-
-48.33M
137.18%
-39.83M
17.58%
-255.90M
542.51%
tangible book value per share
1.40
-
-0.52
137.18%
-3.57
585.11%
-13.88
289.19%
working capital
191.43M
-
5.67M
97.04%
183.03M
3,130.93%
57.74M
68.45%

All numbers in USD (except ratios and percentages)